Daridorexant considered appropriate for chronic insomnia across heterogeneous clinical profiles, consensus says
Experts Say Daridorexant Fits Many Insomnia Profiles
This guideline consensus, based on expert opinion from a multidisciplinary panel, addresses the use of daridorexant in chronic insomnia. It …
A new expert consensus says daridorexant may help chronic insomnia across very different patient types, with low abuse potential.
Daridorexant improves objective and subjective insomnia markers with dose-dependent efficacy across multiple trials
New data shows daridorexant helps people with insomnia sleep better
This meta-analysis of 2905 patients found that daridorexant outperformed placebo in both objective and subjective sleep indicators for insom…
Daridorexant shows promise for treating insomnia by improving sleep time and quality, though some side effects are linked to specific doses.
Daridorexant 25 or 50 mg improved sleep parameters in patients with comorbid insomnia disorder and untreated mild obstructive sleep apnoea
New Hope for Sleep Without Risking Breathing
This post hoc subgroup analysis of a Phase 3 randomized clinical trial evaluated daridorexant in patients with comorbid insomnia disorder an…
You lie in bed for hours, wide awake. You’re exhausted—but your mind won’t shut off.